EUVIMEDEUVIMED entdecken
Open Access

Unfractionated Heparin Safety in COVID-19: Incidence and Risks of Bleeding Complications in Japan

Lubna Sato, Noriko Iwamoto, Yuko Kakumoto, Shinya Tsuzuki, Tomiteru Togano, Masahiro Ishikane, Nobumasa Okumura, Gen Yamada, Makoto Inada, Tetsuya Suzuki, Masayuki Hojo, Jin Takasaki und 8 weitere

Journal of Atherosclerosis and Thrombosis · 2024

DOI: 10.5551/jat.64448 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Atherosclerosis and Thrombosis, 2024. Verfasst von Lubna Sato und 19 weiteren Autor:innen. Beteiligte Einrichtung: Disease Control and Prevention Center, National Center for Global Health and Medicine. Hauptthemen laut MEDLINE: Hemorrhage, COVID-19, Heparin, Anticoagulants. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HemorrhageCOVID-19HeparinAnticoagulantsHumansMaleFemaleJapanRetrospective StudiesAgedMiddle AgedIncidenceRisk FactorsSARS-CoV-2COVID-19 Drug TreatmentAged, 80 and overThromboembolism

Stichwörter der Autor:innen

Bleeding complicationBleeding risk factorsCOVID-19Unfractionated heparinVenous thromboembolism

Substanzen

HeparinAnticoagulants

Autor:innen und Institutionen

  • Disease Control and Prevention Center, National Center for Global Health and Medicine.
  • Department of Emergency and Critical Care Medicine, Fukushima Medical University.
  • AMR Clinical Reference Center, National Center for Global Health and Medicine.
  • Department of Hematology, National Center for Global Health and Medicine.
  • Department of Respiratory Medicine, National Center for Global Health and Medicine.
  • Department of Emergency Medicine and Critical Care, National Center for Global Health and Medicine.

Zitieren

APA

Sato, L., Iwamoto, N., Kakumoto, Y., Tsuzuki, S., Togano, T., Ishikane, M., Okumura, N., Yamada, G., Inada, M., Suzuki, T., Hojo, M., Takasaki, J., Sasaki, R., Kimura, A., Teruya, K., Okamoto, T., Hayakawa, K., Hara, H., Iseki, K., & Ohmagari, N. (2024). Unfractionated Heparin Safety in COVID-19: Incidence and Risks of Bleeding Complications in Japan. Journal of Atherosclerosis and Thrombosis. https://doi.org/10.5551/jat.64448

Vancouver

Sato L, Iwamoto N, Kakumoto Y, Tsuzuki S, Togano T, Ishikane M, et al. Unfractionated Heparin Safety in COVID-19: Incidence and Risks of Bleeding Complications in Japan. Journal of Atherosclerosis and Thrombosis. 2024. doi:10.5551/jat.64448

BibTeX
@article{Sato2024,
  author = {Sato, Lubna and Iwamoto, Noriko and Kakumoto, Yuko and Tsuzuki, Shinya and Togano, Tomiteru and Ishikane, Masahiro and Okumura, Nobumasa and Yamada, Gen and Inada, Makoto and Suzuki, Tetsuya and Hojo, Masayuki and Takasaki, Jin and Sasaki, Ryo and Kimura, Akio and Teruya, Katsuji and Okamoto, Tatsuya and Hayakawa, Kayoko and Hara, Hisao and Iseki, Ken and Ohmagari, Norio},
  title = {Unfractionated Heparin Safety in COVID-19: Incidence and Risks of Bleeding Complications in Japan},
  journal = {Journal of Atherosclerosis and Thrombosis},
  year = {2024},
  doi = {10.5551/jat.64448}
}
Kostenlos starten →